|
1. Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, et al. Treating childhood acute lymphoblastic leukemia without prophylactic cranial irradiation. N Engl J Med. 2009 Jun; 360(26): 2730-41. doi:10.1056/NEJMoa0900386 2. Pickering LK, Baker CJ, Long SS, McMillanassociate JA. Red Book: 2006 Report of the Committee on Infectious Diseases. 27th ed. Elk Grove, Illinois: American Academy of Pediatrics. 2006; pp: 711-25. 3. Balkis MM, Ghosn S, Sharara AI, Atweh SF, Kanj SS. Disseminated varicella presenting as acute abdominal pain nine days before the appearance of the rash. Int J Infect Dis. 2009 May; 13(3): e93-5. doi:10.1016/j.ijid.2008.06.036 4. Kernbach-Wighton G, Oehmichen M, Saternus KS. Fatal outcome of varicella in children. Leg Med (Tokyo). 2003 Mar; 5(Suppl 1): S233-6. 5. Caniza MA, Hunger SP, Schrauder A, Valsecchi MG, Pui CH, Masera G. The controversy of varicella vaccination in children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2012 Jan; 58(1): 12-6. doi:10.1002/pbc.22759 6. Schrauder A, Henke-Gendo C, Seidemann K, Sasse M, Cario G, Moericke A, et al. Varicella vaccination in a child with acute lymphoblastic leukaemia. The Lancet. 2007 Jul; 369(9568): 1232. http://dx.doi.org/10.1016/S0140-6736(07)60567-4 7. Perez-Farinos N, Garcia-Comas L, Ramirez-Fernandez R, Sanz JC, Barranco D, Garcia-Fernandez C, Ordobas M. Seroprevalence of antibodies to varicella-zoster virus in Madrid (Spain) in the absence of vaccination. Cent Eur J Public Health. 2008 Mar; 16(1): 41-4. 8. Kurukulasooriya GM, Thevanesam V, Agampodi SB, Abeykoon AM, Amarasiri SP, Goonasekera KP. Susceptibility of New Entrant University students in Sri Lanka to varicella zoster infection. Asia Pac J Public Health. 2010 Apr; 22(2): 219-24. doi:10.1177/1010539509334625 9. Crawford NW, Heath JA, Ashley D, Downie P, Buttery JP. Survivors of childhood cancer: an Australian audit of vaccination status after treatment. Pediatr Blood Cancer. 2010 Jan; 54(1): 128-33. doi:10.1002/pbc.22256 10. Bhave SY. Controversies in chicken-pox immunization. Indian J Pediatr. 2003 Jun; 70(6): 503-7. 11. Sharifi Z, Emadi Ghanjin S. The seroepidemiology of Varicella Zoster Virus (VZV) in different age groups in Tehran, Iran. Iran J Allergy Asthma Immunol. 2005 Jun; 4(2): 95-8. 12. Ziyaeyan M, Alborzi A, Jamalidoust M, Moieni M, Pourabbas B. Seroepidemiology of Varicella Zoster Virus infection among 1-70 year individuals in Iran. Iranian Red Crescent Medical Journal. 2010; 12(2): 176-180. 13. Pourakbari B, Shahbaznezhad L, Parvaneh N, Nikkhah S, Mahmoudi S, Teymuri M, et al. Seroepidemiology of Varicella Zoster Virus among children, adolescents and medical students in a referral children medical center, Tehran, Iran. Iran J Microbiol. 2012 Sep; 4(3): 136-8. 14. Ehsanipour F, Shayanfar N, Salariyan K. [Surveying of protective antibody against varicella zoster virus (VZV) infection in children referring to Hzrat-e-Rasool Akram hospital (2005)]. Razi Journal of Medical Sciences. 2009; 16(64): 38-44. [Article in Persian] 15. Alp H, Altinkaynak S, Ertekin V, Kiliçaslan B, Giiraksin A. Seroepidemiology of varicella-zoster virus infection in a cosmopolitan city (Erzurum) in the eastern Turkey. Health Policy. 2005 Apr; 72(1): 119-24. 16. Akram DS, Qureshi H, Mahmud A, Khan AA, Kundi Z, Shafi S, et al. Seroepidemiology of varicella-zoster in Pakistan. Southeast Asian J Trop Med Public Health. 2000 Dec; 31(4): 646-9.
|
